Dr. Leung To Wai - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- TrilingualCantonese · English · Putonghua
- 1 LocationsCentral
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Fellow of the Royal College of Radiologists · Fellow of the Hong Kong College of Radiologists · Medical degree 1985
- InsuranceBeing compiled｜See details
About
Dr. Leung To Wai practises Clinical Oncology in Central, Hong Kong. They speaks Cantonese, English, Putonghua.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1985
- Fellow of the Royal College of RadiologistsFellow of the Royal College of Radiologists1991
- Fellow of the Hong Kong Academy of Medicine (Radiology)Fellow of the Hong Kong Academy of Medicine (Radiology)1993
- Doctor of Medicine (MD)Doctor of Medicine (MD)2007
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists1993
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
希愈腫瘤中心
Unit 16, Entertainment Building, 30 Queen’s Road Central, Hong Kong
Get Directions →Weekly Hours
| Monday | 9:00 AM - 6:00 PM |
| Tuesday | 9:00 AM - 6:00 PM |
| Wednesday | 9:00 AM - 6:00 PM |
| Thursday | 9:00 AM - 6:00 PM |
| Friday | 9:00 AM - 6:00 PM |
| Saturday | 9:00 AM - 1:00 PM |
| Sunday | Hours not available |
Central
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Leung To Wai? Claim page and update insurance →
Hospital Affiliations
Referrals available to these hospitals
FAQ
Is Dr. Leung To Wai any good?
Dr. Leung To Wai practises Clinical Oncology in Central, Hong Kong. They speaks Cantonese, English, Putonghua. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Leung To Wai do?
Dr. Leung To Wai practises in Clinical Oncology.
Where does Dr. Leung To Wai practise?
Dr. Leung To Wai practises at 希愈腫瘤中心.
Is Dr. Leung To Wai open on Saturdays?
Yes, Dr. Leung To Wai has Saturday opening hours at 希愈腫瘤中心.
What languages does Dr. Leung To Wai speak?
Dr. Leung To Wai speaks Cantonese, English, Putonghua.
Are you Dr. Leung To Wai? Claim this page to update and manage.
ClaimResearch and publications
29 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled Trial.JAMA network open · 2024
- Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma Patients.Cancers · 2024
- Frameless versus frame-based stereotactic radiosurgery for intracranial arteriovenous malformations: A propensity-matched analysis.Clinical and translational radiation oncology · 2023
- SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.Cancers · 2022
- International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.The Lancet. Oncology · 2022
- Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.Oral oncology · 2022
- Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.Hepatology (Baltimore, Md.) · 2021
- Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases.Radiation oncology journal · 2021
- Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report.BMC infectious diseases · 2021
- Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.Frontiers in oncology · 2020
- The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.International journal of cancer · 2019
- Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.Surgical oncology · 2019
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer